Why venture capitalists are investing in Singapore’s health and biomedicine start-up ecosystem

The rapid pace of medical innovation and transformation during the Covid-19 pandemic radically changed how Singapore-based investor Chik Wai Chiew imagined he and his company could have an impact on society. The CEO and executive director of Heritas Capital, a private-equity and venture-capital (VC) company, realised it was essential to...

Read more...

Heritas Capital announces the launch of US$50 million Asia Impact First Fund to scale innovative and high-growth social enterprises across Asia for greater social and environmental impact

Heritas Capital1 announces the launch of Asia Impact First Fund (AIFF), with a proposed fund size of US$50 million, to back 10 to 15 innovative and high-growth social enterprises across Asia. AIFF will provide growth capital to social enterprises with a clear and demonstrated social and/or environmental impact, and...

Read more...

Heritas Capital continues backing Tessa Therapeutics in its US$126 million Series A round led by Polaris Partners

Heritas-backed Tessa Therapeutics has raised US$126 million in a Series A funding round led by US healthcare investor Polaris Partners, alongside existing investors Temasek, EDBI, Heliconia Capital and Heritas Capital. “Heritas Capital is pleased to join Polaris Partners, Temasek, EDBI and Heliconia Capital in backing Tessa Therapeutics to advance its...

Read more...

HealthBeats raises US$3m Seed funding led by Heritas Capital and SEEDS Capital to expand remote vitals monitoring in Australia and Singapore

HealthBeatsTM, a Singapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of a US$3m Seed round led by healthcare investor Heritas Capital together with SEEDS Capital, the investment arm of government agency Enterprise Singapore. The HealthBeatsTM Remote Vitals Monitoring platform provides healthcare providers and patients with a simple-to-use and...

Read more...

Heritas Capital’s newly launched Growth Fund III leads US$20m Series B round in Jio Health, Vietnam’s leading human-centered and technology-powered healthcare provider

Heritas Capital, through its newly launched Heritas Growth Fund III (HGF III), is pleased to have led the US$20m Series B round in Jio Health, a leading provider of human-centered, technology-powered healthcare in Vietnam. Other investors included Fuchsia Ventures, Kasikorn Bank Group and existing investor Monk's Hill Ventures. This fundraise...

Read more...